A Clinical Study to Evaluate the Long-term Safety and Tolerability of an Investigational Drug in People With Schizophrenia
A Clinical Trial That Will Study the Efficacy and Safety of an Investigational Drug in Acutely Psychotic People With Schizophrenia
A Clinical Trial to Study the Efficacy and Safety of an Investigational Drug in Acutely Psychotic People With Schizophrenia
A Double-Blind, Controlled Study of Aripiprazole in Co-Morbid Schizophrenia and Cocaine Dependence
A Multiple Dose Study to Assess the Safety, Tolerability and PK of Risperidone Extended Release Capsules in Subjects With Schizophrenia, Schizoaffecti
A Neurofeedback Intervention to Improve Working Memory in Schizophrenia
A Pharmaco-imaging Approach to Predicting Social Functioning and Clinical Responses to Oxytocin Administration in Schizophrenia
A Study to Assess Efficacy and Safety of Adjunctive KarXT in Subjects With Inadequately Controlled Symptoms of Schizophrenia
A Study to Assess Efficacy and Safety of KarXT in Acutely Psychotic Hospitalized Adult Patients With Schizophrenia (EMERGENT-3)
A Study to Assess the Effects of RO6889450 (Ralmitaront) in Participants With Schizophrenia or Schizoaffective Disorder and Negative Symptoms
A Study to Evaluate Iloperidone Long-acting Injection (LAI) for the Treatment of Schizophrenia
A Study to Test Long-term Safety of BI 425809 in People With Schizophrenia Who Took Part in a Previous CONNEX Study
A Translational and Neurocomputational Evaluation of a Dopamine Receptor 1 Partial Agonist for Schizophrenia
Acetazolamide for Treatment Resistant Schizophrenia
Adjunctive Vortioxetine in Schizophrenia
Adjunctive Withania Somnifera (Ashwagandha) for Persistent Symptoms in People With Schizophrenia
Aging and Disease Course: Contributions to Lifespan Neurobiology of Schizophrenia
An Extension Study to Assess Long-Term Safety and Tolerability of Adjunctive KarXT in Subjects With Inadequately Controlled Symptoms of Schizophrenia
An Extension Study to Assess Long-term Safety, Tolerability, and Efficacy of KarXT in Adult Patients With Schizophrenia (EMERGENT-4)
An Open-label Study to Assess the Long-term Safety, Tolerability, and Efficacy of KarXT in Adult Patients With Schizophrenia (EMERGENT-5)
Aripiprazole for Co-Morbid Schizophrenia and Cocaine Dependence
Aripiprazole Lauroxil for Preventing Psychotic Relapse After an Initial Schizophrenia Episode
Biomarkers of Conversion Risk and Treatment Response in Early-Stage Schizophrenia
Bromocriptine for Patients With Schizophrenia and Impaired Glucose Tolerance
BXCL501 for Agitation in Schizophrenia
Can Neural Network Instability in Schizophrenia be Improved With a Very Low Carbohydrate Ketogenic Diet?
Carnosine and Cognitive Training in Schizophrenia
Cigarette Smoking in Smokers With and Without Schizophrenia
Clinical Trial of BI 425809 Effect on Cognition and Functional Capacity in Schizophrenia (CONNEX-1)
Clinical Trial of BI 425809 Effect on Cognition and Functional Capacity in Schizophrenia (CONNEX-2)
Clinical Trial of BI 425809 Effect on Cognition and Functional Capacity in Schizophrenia (CONNEX-3)
Clozapine for the Prevention of Violence in Schizophrenia: a Randomized Clinical Trial
Confirmatory Efficacy Trial of a Gluten-Free Diet in a Subgroup of Persons With Schizophrenia Who Have High Levels of IgG Anti-Gliadin Antibodies (AGA
Cromoglycate Adjunctive Therapy for Outpatients With Schizophrenia
Deep Brain Stimulation in Treatment Resistant Schizophrenia
Determining Efficacy and Safety of BXCL501 in Agitation Associated With Pediatric Schizophrenia and Bipolar Disorder
D-Serine Treatment of Negative Symptoms and Cognitive Deficits in Schizophrenia
Early-Phase Schizophrenia: Practice-based Research to Improve Outcomes
Effectiveness of Tropisetron Plus Risperidone for Improving Cognitive and Perceptual Disturbances in Schizophrenia
Effects of Auditory Stimulation on Sleep and Memory in Schizophrenia
Effects of Brain Stimulation on Cognition, Oscillations and GABA Levels in Schizophrenia
Effects of Eszopiclone on Sleep and Memory in Schizophrenia
Effects of Low-dose Levetiracetam on Clinical Symptoms, Cognition and Hippocampal Hyperactivity in Schizophrenia
Efficacy and Safety of MK-8189 in Participants With an Acute Episode of Schizophrenia (MK-8189-008)
Efficacy of Cognitive Remediation in Patients With Schizophrenia or Schizoaffective Disorder Stabilized on Lurasidone
Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Negative Symptoms of Schizophrenia
Enhancing Cognitive Training Through Exercise Following a First Schizophrenia Episode
Enhancing Prefrontal Oscillations and Working Memory in Early-course Schizophrenia
ERG Components in Schizophrenia and Bipolar Disorder Type I
Evaluation of a Visual Remediation Intervention for Schizophrenia
First-in-Human Study to Evaluate AMG 579 in Healthy Subjects and Patients With Stable Schizophrenia
Functional Relevance of Dopamine Receptors in Healthy Controls and Patients With Schizophrenia: Characterization Through [11C]NNC-112 and [18F]Fallypr
Genetic Study of Schizophrenia
Impact of a Ketogenic Diet on Metabolic and Psychiatric Health in Patients With Bipolar or Schizophrenia Illness
Impact of Inflammation on Reward Circuits, Motivational Deficits and Negative Symptoms in Schizophrenia
Improving Cognition Via Exercise in Schizophrenia
Improving Negative Symptoms and Community Engagement in Veterans With Schizophrenia
Improving Outcome in Schizophrenia Through Identification of Genetic Risk Factors
Inpatient Evaluation of Adults With Schizophrenia
Interactions of Fronto-Parietal High Frequency rTMS on Anterior Cingulate Cortex Activation in Schizophrenia
Journey Study: Evaluate the Efficacy, Safety, and Tolerability of Valbenazine as Adjunctive Treatment for Schizophrenia
Lumateperone for the Prevention of Relapse in Patients With Schizophrenia
M1 Schizophrenia PET Study
Medial-prefrontal Enhancement During Schizophrenia Systems Imaging
Memantine Augmentation of Targeted Cognitive Training in Schizophrenia
Memantine Effects on Sensorimotor Gating and Neurocognition in Schizophrenia
Minocycline Augmentation in Schizophrenia
Neuromodulation of Social Cognitive Circuitry in People With Schizophrenia Spectrum Disorders
Neuronal Effects of Exercise in Schizophrenia
Neuroplasticity in TBI and Schizophrenia
N-methyl-D-aspartic Acid (NMDA) and Cognitive Remediation in Schizophrenia
Observational Study Evaluating the Safety of ADASUVE® in Agitation Associated With Schizophrenia or Bipolar I Disorder
Peripheral Immune System in Individuals With Schizophrenia
Pharmacokinetics, Safety, and Tolerability of Lumateperone Long-Acting Injectable in Patients With Schizophrenia
Pharmacologic Augmentation of Targeted Cognitive Training in Schizophrenia
Prebiotic Treatment in People With Schizophrenia
Promoting Activity and Cognitive Enrichment in Schizophrenia (PACES)
Proposal To Develop A Rapid And Cost-Effective Diagnostic Test For Schizophrenia
Real-time fMRI Neurofeedback in Patients With Schizophrenia and Auditory Hallucinations
Reducing Hippocampal Hyperactivity and Improving Cognition in Schizophrenia
Remediation of Visual Perceptual Impairments in Schizophrenia
Repetitive TMS & Cognitive Training in Adults With Schizophrenia
Rt-fMRI Neurofeedback and AH in Schizophrenia
rTMS as a Probe of Episodic Memory Neurocircuitry in Schizophrenia
Safety and Efficacy of Brilaroxazine (RP5063) in Schizophrenia
Safety and Tolerability of Open-Label Flexible-dose Brexpiprazole as Maintenance Treatment in Adolescents With Schizophrenia
Safety, Tolerability, and Pharmacokinetics of Lumateperone in Pediatric Patients With Schizophrenia or Schizoaffective Disorder
Siltuximab in Schizophrenia
Smoking Cessation With Varenicline in Schizophrenia: Antipsychotic-Induced Neurological Symptoms as Correlates
Sodium Nitroprusside in Early Course Schizophrenia
Study to Assess the Safety and Pharmacokinetics of CY6463 in Participants With Stable Schizophrenia
Study to Evaluate Safety & Efficacy of NaBen® as Add-on Treatment for Schizophrenia in Adults
Study to Evaluate the Efficacy, Safety, and Tolerability of Luvadaxistat in Subjects With Cognitive Impairment Associated With Schizophrenia
Study to Evaluate the PK Profiles of LY03010 in Patients With Schizophrenia or Schizoaffective Disorder
Suicide Prevention Intervention for Schizophrenia-Spectrum Disorders
Targeted Vitamin D Treatment of Schizophrenia-Associated Hyperprolinemia
The Effects of Kynurenine Aminotransferase Inhibition in People With Schizophrenia
The Effects of tDCS on the Neuronal Mechanisms of Cognitive Control in Schizophrenia
This Study Tests Whether BI 425809 Together With Brain Training Using a Computer Improves Mental Functioning in Patients With Schizophrenia
TMS for Symptom Reduction in Schizophrenia
Tocilizumab in Schizophrenia
Trial to Evaluate the Short-term Safety & Efficacy of Brexpiprazole Monotherapy in the Treatment of Adolescents With Schizophrenia
Trial to Study the Effect of CVL-231 on 24-Hour Ambulatory Blood Pressure in Participants With Schizophrenia
Using Transcranial Magnetic Stimulation (TMS) to Understand 'Negative' Symptoms of Schizophrenia
Virtual Reality Training for Social Skills in Schizophrenia - Comparison With Cognitive Training